| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1805 | Dipicrylamine Sodium Salt | Potent antagonist of GABA A receptors that contain alpha1 and beta2 subunits |
|
| DCC1806 | Dipquo | Novel activator of the bone marker alkaline phosphatase (ALP), markedly promoting osteoblast differentiation, including expression of Runx2, Osterix, and Osteocalcin, mediating osteogenesis through activation of p38-β |
|
| DCC1807 | Dipraglurant | Novel negative allosteric modulator of the mGlu5 receptor |
|
| DCC1808 | Displurigen | Inhibitor of ATPase activity of HSP70 |
|
| DCC1809 | Distamycin A Hydrochloride | Antibiotic, specifically inhibiting the initiation of RNA synthesis, binding isohelically to the minor groove of B-DNA at A/T rich sites |
|
| DCC1810 | Distigmine Dibromide | Parasympathomimetic with longer duration of action |
|
| DCC1811 | Djt06001 | Novel selective Factor Xa inhibitor, reducing thrombus formation with low risk of bleeding |
|
| DCC1812 | Dk-1-150 | Novel inducer of apoptotic cell death in TNBC cell lines without causing cytotoxicity in the normal mammary epithelial cell line |
|
| DCC1813 | Dk-1-166 | Novel inducer of apoptotic cell death in TNBC cell lines without causing cytotoxicity in the normal mammary epithelial cell line |
|
| DCC1814 | Dk-139 | Inhibitor of NF-kappaB-mediated GROalpha expression, suppressing the TNFalpha-induced invasive capability of MDA-MB-231 human breast cancer cells |
|
| DCC1815 | Dk-1-49 | Novel autophagonizer, inducing autophagic cell death in apoptosis-defective cell line |
|
| DCC1816 | Dl0410 | Novel acetylcholinesterase inhibitor, promoting synaptic function and neuronal survival, ameliorating cognitive deficits in SAMP8 mice via improved mitochondrial dynamics and increased activity of the NMDAR-CREB-BDNF pathway |
|
| DCC1817 | D-lana-14 | Novel potent anti-MRSA agent, disrupting biofilms with no resistance development, sensitizing rifampicin and tetracycline against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa |
|
| DCC1818 | Dlc27-14 | Specific protein disorder catalyzer of HIV-1 Nef |
|
| DCC1819 | Dl-threo-dihydrosphingosine | Competitive inhibitor of both SPHK1 and SPHK2 |
|
| DCC1820 | D-luciferin Phosphate Sodium Salt | Ultrasensitive bioluminogenic enzyme substrate |
|
| DCC1821 | D-lys(z)-pro-arg-pna | Chromogenic peptide substrate, being highly sensitive for the measurement of activated Protein C. |
|
| DCC1822 | Dma-cpptl | Prodrug of CPPTL, inducing apoptosis in a dose-dependent manner via the ROS/JNK pathway in acute myeloid leukemia |
|
| DCC1823 | Dmako-20 | Novel multi-target anticancer prodrug activated by the tumor specific CYP1B1 enzyme, potently inhibiting HCT-15, HCT-116 and K562 cells growth, showing moderate anti-proliferative activity towards MDA-MB-231, HepG2, PANC, Bel7402 and MGC803 cancer cells, |
|
| DCC1824 | Dmako-5 | Novel antineoplastic agent, exhibiting remarkable anticancer activity as well as excellent cellular selectivity |
|
| DCC1825 | D-mannuronic Acid [6906-37-2] | Novel blocker of the TLR2 and TLR4 downstream signaling pathway, effectively inhibiting mRNA expression of MyD88 and p65, major subunit of nuclear factor-kappaB |
|
| DCC1826 | Dmb213 | Novel non-nucleoside inhibitor of Zika viral RNA-dependent RNA polymerase (RdRp) enzymes |
|
| DCC1827 | Dmcl1-2 | Novel potent and selective PROTAC degrader of myeloid cell leukemia 1 (MCL1) |
|
| DCC1828 | Dmnpe-caged Luciferin | Novel cell permeable caged Luciferin |
|
| DCC1829 | Dmocptl | Novel inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells |
|
| DCC1830 | Dmt-dalda | Potent and highly selective µ opioid agonist |
|
| DCC1831 | Dmxb-a | Novel,orally active and selective alpha-7 nicotinic acetylcholine (nACh) receptor |
|
| DCC1832 | Dna Primase Inhibitor-1 | Novel DNA primase inhibitor |
|
| DCC1833 | Dna Primase Inhibitor-13 | Novel DNA primase inhibitor |
|
| DCC1834 | Dnac-1 | Novel potentiator of β-lactam activity against Gram positive and Gram negative pathogens |
|
